Zhengdong Zhang
Papers
1
Total Citations
22
H-Index
1
About
Zhengdong Zhang is a clinical researcher whose work has made meaningful contributions to the field of urological oncology, with a particular focus on the surgical and interventional management of renal cell carcinoma. His most prominent contribution, a 2014 systematic review and meta-analysis comparing radiofrequency ablation with partial nephrectomy for the treatment of clinical stage 1 renal masses, addressed a critical and evolving question in kidney cancer care. As the incidence of small renal masses increased alongside advances in minimally invasive technologies, Zhang's work provided clinicians with a rigorous, evidence-based synthesis to guide treatment decision-making. By systematically evaluating comparative outcomes across multiple studies, his research helped clarify the trade-offs between ablative and nephron-sparing surgical approaches, informing real-world clinical practice. With 22 citations, the work has demonstrated sustained relevance within the urological literature. Zhang's scholarship reflects a commitment to translating complex clinical data into actionable insights, positioning him as a thoughtful contributor to the ongoing refinement of kidney cancer treatment paradigms and a valuable voice in the minimally invasive oncology research community.
Research Focus
Key Achievements
Top Papers
- 1